Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Effect of policosanol on hyperlipidemia and coronary heart disease in middle-aged patients. A 14-month pilot study.

Batista J, Stüsser R, Saéz F, Pérez B.

Int J Clin Pharmacol Ther. 1996 Mar;34(3):134-7.

PMID:
8705091
[PubMed - indexed for MEDLINE]
2.

Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.

Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I.

JAMA. 2006 May 17;295(19):2262-9.

PMID:
16705107
[PubMed - indexed for MEDLINE]
3.

Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.

Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.

Int J Clin Pharmacol Res. 2002;22(3-4):89-99.

PMID:
12837046
[PubMed - indexed for MEDLINE]
4.

Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.

Castaño G, Fernández L, Mas R, Illnait J, Gámez R, Mendoza S, Mesa M, Fernández J.

Drugs R D. 2005;6(4):207-19.

PMID:
16050054
[PubMed - indexed for MEDLINE]
5.

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.

Castaño G, Mas R, Fernández L, Illnait J, Mesa M, Alvarez E, Lezcay M.

Drugs Aging. 2003;20(2):153-63.

PMID:
12534315
[PubMed - indexed for MEDLINE]
6.

Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.

Castaño G, Mas R, Fernández L, Illnait J, Gámez R, Alvarez E.

Int J Clin Pharmacol Res. 2001;21(1):43-57.

PMID:
11708574
[PubMed - indexed for MEDLINE]
7.

Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.

Castaño G, Más R, Fernández JC, Fernández L, Illnait J, López E.

Drugs R D. 2002;3(3):159-72.

PMID:
12099160
[PubMed - indexed for MEDLINE]
8.

Long-term therapy with policosanol improves treadmill exercise-ECG testing performance of coronary heart disease patients.

Stüsser R, Batista J, Padrón R, Sosa F, Pereztol O.

Int J Clin Pharmacol Ther. 1998 Sep;36(9):469-73.

PMID:
9760006
[PubMed - indexed for MEDLINE]
9.

Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.

Mirkin A, Mas R, Martinto M, Boccanera R, Robertis A, Poudes R, Fuster A, Lastreto E, Yañez M, Irico G, McCook B, Farré A.

Int J Clin Pharmacol Res. 2001;21(1):31-41.

PMID:
11708573
[PubMed - indexed for MEDLINE]
10.

Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.

Pons P, Rodríguez M, Robaina C, Illnait J, Más R, Fernández L, Fernández JC.

Int J Clin Pharmacol Res. 1994;14(1):27-33.

PMID:
7927958
[PubMed - indexed for MEDLINE]
12.

Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.

Greyling A, De Witt C, Oosthuizen W, Jerling JC.

Br J Nutr. 2006 May;95(5):968-75.

PMID:
16611388
[PubMed - indexed for MEDLINE]
13.
14.

Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.

Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A.

Int J Clin Pharmacol Res. 1999;19(4):105-16.

PMID:
10939028
[PubMed - indexed for MEDLINE]
15.

Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.

Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G.

Pharmacotherapy. 2005 Feb;25(2):171-83. Review.

PMID:
15767233
[PubMed - indexed for MEDLINE]
16.

Concomitant use of policosanol and beta-blockers in older patients.

Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.

Int J Clin Pharmacol Res. 2004;24(2-3):65-77.

PMID:
15689053
[PubMed - indexed for MEDLINE]
17.

A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.

Castaño G, Más R, Roca J, Fernández L, Illnait J, Fernández JC, Selman E.

Angiology. 1999 Feb;50(2):123-30.

PMID:
10063942
[PubMed - indexed for MEDLINE]
18.

Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.

Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.

Am Heart J. 2006 Nov;152(5):982.e1-5.

PMID:
17070175
[PubMed - indexed for MEDLINE]
19.

Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.

Castaño G, Más R, Fernández JC, Illnait J, Fernández L, Alvarez E.

J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M186-92.

PMID:
11253161
[PubMed - indexed for MEDLINE]
20.

A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.

Castaño G, Más R, Fernández L, Illnait J, Mendoza S, Gámez R, Fernández J, Mesa M.

Drugs Exp Clin Res. 2005;31 Suppl:31-44.

PMID:
16444910
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk